Table 2—

Risk factor means ± SD at baseline and 1-year follow-up

Female subjects
Male subjects
BaselineFollow-upF valueBaselineFollow-upF value
n2702269177
Weight86.0 ± 13.285.5 ± 13.3NS100.0 ± 18.198.5 ± 18.17.556*
BMI32.5 ± 4.632.3 ± 4.7NS32.0 ± 5.331.5 ± 5.28.046*
Waist circumference (cm)102.8 ± 10.7101.6 ± 10.913.143110.6 ± 12.6108.3 ± 13.122.345
Plasma glucose (mmol/l)
    Fasting glucose5.6 ± 0.85.7 ± 0.76.998*5.9 ± 0.76.1 ± 0.8NS
    2-h tolerance test6.5 ± 1.76.6 ± 1.9NS6.9 ± 1.86.8 ± 2.3NS
Serum lipids (mmol/l)
    Total cholesterol5.5 ± 1.05.5 ± 0.9NS5.3 ± 0.95.1 ± 0.8NS
    HDL cholesterol1.5 ± 0.41.5 ± 0.4NS1.3 ± 0.31.4 ± 0.3NS
    Triglycerides1.6 ± 0.81.5 ± 0.7NS1.6 ± 0.81.6 ± 1.0NS
Blood pressure (mmHg)
    Systolic141 ± 17140 ± 18NS146 ± 20143 ± 16NS
    Diastolic87 ± 986 ± 9NS91 ± 1187 ± 89.873*
  • Data are means ± SD. Repeated-measures ANOVA F test.

  • *

    * P < 0.01;

  • P < 0.001.